27th Clinical Trials Innovation Program

Event Schedule

Have a look at Schedule

Day 1
Day 2

08:00

Registration & Itinerary Collection

08:50

Welcome Remarks from World BI

Amraj Dhillon

Key Account Manager

World BI

08:55

Chairperson Welcome Address

Isabelle Naëije, PMP

Assoc. Global Trial Director

Novartis

09:00

Presentation 1: Maintenance of ethical balance between research strategy and clinical trial efficacy

Tali Schaffer

Exe. Director (develop treatments to neometals)

ELGAN Pharma

09:25

Presentation 2: Concept of smart trials: New technique to optimize clinical studies

09:50

Interactive Discussion: Redesigning the Clinical Research Environment

Panelists:

Isabelle Naëije, PMP

Assoc. Global Trial Director

Novartis

Dr. Andriy Krendyukov

VP Medical Affairs

10:20

Coffee Break & Networking Session

11:10

Presentation 3: Patient represent the "last mile of knowledge" to improve clinical outcomes

Sensitivity and knowledge when it comes to patients

The 'Modern Role' of patient in the Healthcare System

Rethink Patient Journey in a 360° holistic view

Andrea Forgione, HSBA

Global Lead, Patient Engagement & Advocacy - Owner of Global Trasparency Process

MENARINI Group

11:35

Presentation 4: Guiding Clinical Research by Involving Patients from A to Z, to improve quality and success

Francois Houyez

Treatment Information and Access Director / Health Policy Advisor

European Organisation for Rare Diseases (Eurordis)

12:00

Presentation 5: Improving patient engagement by reducing barriers in clinical trials

12:25

Presentation 6: Regulatory Guidelines for Patient Data Transparency in Clinical Trials

Dr Solange Corriol-Rohou, MD

Senior Director Regulatory Affairs & Policy, Europe

AstraZeneca

12:55

Lunch Break

13:55

Fire Side Chat: Clinical Operations 3.0….What will Clinical Operations look like in the year 2050

Moderator

Bernhard Glombitza

Head Clinical Operations EMEA & APAC, VP

Bayer Pharmaceuticals

Panelist:-

Jessica Cordes

Senior Clinical Operations Expert

14:35

Presentation 7: Clinical trials with cell and gene therapy along with key operational elements and best practises

Jessica Cordes

Senior Clinical Operations Expert

15:00

Presentation 8: GCP (Good Clinical Practices) Quality and Risks in Decentralized Clinical Trials

Konstantinos Tsekmes

Associate Director Clinical Operations

MSD

15:25

Coffee Break & Networking Session

16:15

Interactive Discussion: Rare diseases and decentralized clinical trials

Moderator:-

Dr Solange Corriol-Rohou, MD

Senior Director Regulatory Affairs & Policy, Europe

AstraZeneca

Panelist:-

Dr. Andriy Krendyukov

VP Medical Affairs

16:45

Presentation 9: The era of Precision Medicine for clinical oncology trials: Current Context, Best Operational Practices

Dr. Harsha Doddihal

Vice President Clinical Development

Glenmark Pharmaceuticals

17:05

Interactive Discussion: Decentralized Clinical Trials or AI in clinical trials?

Isabela Niculae, MPH

Head Global Clinical Sciences & Operations Innovation

UCB

17:35

Chair Closing Remarks

Isabelle Naëije, PMP

Assoc. Global Trial Director

Novartis

17:40

End of Day 1

08:00

Registration & Itinerary Collection

08:50

Welcome Remarks from World BI

Amraj Dhillon

Key Account Manager

World BI

08:55

Chair Welcome Address

09:00

Presentation 10: Clinical Trials in oncology: Practice-Changing, Landmark Studies with an Emphasis on More Recent Trials

Dr. Ravit Geva

Medical Oncology specialist, Head, GIT malignancies Center, Head, Research Unit, Deputy Director Division of Oncology

Tel Aviv Sourasky Medical Center

09:25

Presentation 11: The Use of Telemedicine in Cancer Clinical Trials

Antonella Cardone

Chief Executive Officer

Cancer Patients Europe - CPE

09:50

Presentation 12: Clinical document templates to make studies more patients centric and other tools to assess and reduce patient burden

Nikita Sharma

Global Clinical Sciences & Operations Innovation Manager

UCB

10:15